These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9600718)

  • 21. Pharmacokinetics and metabolism of endothelin receptor antagonist: contribution of kidneys in the overall in vivo N-demethylation.
    Chong S; Obermeier M; Humphreys WG
    Arch Pharm Res; 2003 Jan; 26(1):89-94. PubMed ID: 12568365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of cerebral pharmacokinetics of the novel antidepressant drug, BMS-181101, by positron emission tomography.
    Christian BT; Livni E; Babich JW; Alpert NM; Dischino DD; Ruediger E; Salazar DE; Ford NF; Fischman AJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):325-31. PubMed ID: 8859010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple pathways are involved in the oral absorption of BMS-262084, a tryptase inhibitor, in rats: role of paracellular transport, binding to trypsin, and P-glycoprotein efflux.
    Kamath AV; Morrison RA; Harper TW; Lan SJ; Marino AM; Chong S
    J Pharm Sci; 2005 May; 94(5):1115-23. PubMed ID: 15793809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Lee MH; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
    J Pharm Sci; 2003 Jan; 92(1):190-201. PubMed ID: 12486695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
    Yang SH; Lee MG
    Biopharm Drug Dispos; 2008 Oct; 29(7):414-26. PubMed ID: 18697186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vivo assessment of extrahepatic metabolism of paeoniflorin in rats: relevance to intestinal floral metabolism.
    Takeda S; Isono T; Wakui Y; Mizuhara Y; Amagaya S; Maruno M; Hattori M
    J Pharm Pharmacol; 1997 Jan; 49(1):35-9. PubMed ID: 9120767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.
    Kim J; Kim EJ; Han KS; Chang MS; Lee MG
    J Pharm Pharmacol; 1999 Sep; 51(9):1031-6. PubMed ID: 10528986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-pass effect of cis-3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)- cyclohexyl)-benzamide (U-54494) in rats--a model with multiple cannulas for investigation of gastrointestinal and hepatic metabolism.
    Zhong WZ; Williams MG; Cook KJ; VandeGiessen TL; Jones BW; Rousch KE
    Pharm Res; 1994 Nov; 11(11):1524-9. PubMed ID: 7870665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability.
    Lee JH; Lee MG
    J Pharm Pharm Sci; 2007; 10(1):37-50. PubMed ID: 17498392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption, distribution and excretion of [14C]-Lesopitron after single and repeated administration in rats and dogs.
    Serafini MT; Puig S; García-Encina G; Farran R; García-Soret A; Moragon T; Martínez L
    Methods Find Exp Clin Pharmacol; 1997; 19(1):61-72. PubMed ID: 9098842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical pharmacokinetics and oral bioavailability of BMS-310705, a novel epothilone B analog.
    Kamath AV; Chang M; Lee FY; Zhang Y; Marathe PH
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):145-53. PubMed ID: 15830240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol.
    Yoon IS; Choi MK; Kim JS; Shim CK; Chung SJ; Kim DD
    Xenobiotica; 2011 Mar; 41(3):243-51. PubMed ID: 21128757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-pass effect of morphine in rats.
    Iwamoto K; Klaassen CD
    J Pharmacol Exp Ther; 1977 Jan; 200(1):236-44. PubMed ID: 833759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic and gastrointestinal first-pass effects of vitexin-4″-O-glucoside in rats.
    Chen Y; Zhang W; Li D; Ai J; Meng Y; Ying X; Kang T
    J Pharm Pharmacol; 2013 Oct; 65(10):1500-7. PubMed ID: 24028617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans.
    Takahashi RH; Choo EF; Ma S; Wong S; Halladay J; Deng Y; Rooney I; Gates M; Hop CE; Khojasteh SC; Dresser MJ; Musib L
    Drug Metab Dispos; 2016 Jan; 44(1):28-39. PubMed ID: 26451002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs.
    Hong H; Su H; Sun H; Allentoff A; Ekhato IV; Chando T; Caceres-Cortes J; Roongta V; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.